Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06350409 · ClinicalTrials.gov registry record

Adolescent Outcomes of Post-operative Opioid EXposure

A clinical trial of Opioid Use Disorder and Pain, Chronic, sponsored by Sharon Levy.

Recruiting
Registry status
20,000
Enrollment target
5
Study locations

NCT06350409: Recruiting study of Opioid Use Disorder and Pain, Chronic, sponsored by Sharon Levy.

NCT06350409 is a study of Opioid Use Disorder and Pain, Chronic that is actively recruiting participants, run by Sharon Levy. The registered enrollment target is 20,000 participants, above the 4,578-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (337% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06350409, a study of Opioid Use Disorder and Pain, Chronic, is actively recruiting participants, sponsored by Sharon Levy.

RECRUITING
Registry status
20,000 participants
Enrollment target
5
Study locations

Study Summary

The goal of this observational study is to examine the factors associated with the transition from medical exposure to opioids with "signposts" of future opioid use disorder among adolescent surgical patients. The main question aims to identify factors (moderators, mediators, and covariates) associated with risk factors for opioid use disorder (ROUD) in the 12 months following major surgery with opioid exposure among adolescents aged 12-17. Participants will be asked to complete electronic surveys pre- and post-operatively and approve the collection of peri-operative data from the Electronic Medical Record to assess correlations.

Primary Outcome

The patient self-report an average pain score of more than 3/10 in the last 7 days on the Brief Pain Inventory (BPI) at 3 or more months postoperatively.

Study Locations (5)

Colorado

  • Children's Hospital Colorado - Aurora

Florida

  • Johns Hopkins All Children's Hospital - St. Petersburg

Massachusetts

  • Boston Childrens Hopsital - Division of Addiction Medicine - Boston

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 20,000 participants
Start Date 2024-11-12
Est. Completion 2028-02
Sharon Levy

1 total trials

What NCT06350409 shows while recruiting

NCT06350409 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 4,578-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (337% higher).

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT06350409 lists 5 locations in 5 states (Colorado, Florida, Massachusetts).

Frequently Asked Questions

What is clinical trial NCT06350409 about?

NCT06350409 is a clinical study titled "Adolescent Outcomes of Post-operative Opioid EXposure". The goal of this observational study is to examine the factors associated with the transition from medical exposure to opioids with "signposts" of future opioid use disorder among adolescent surgical patients. The main question aims to identify factors (moderators, mediators, and covariates) associa...

What is the current status of trial NCT06350409?

This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2024-11-12. Estimated completion is 2028-02.

What conditions does trial NCT06350409 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Pain, Chronic.

Who is sponsoring clinical trial NCT06350409?

This trial is sponsored by Sharon Levy, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06350409 being conducted?

This trial has 5 study locations across Colorado, Florida, Massachusetts, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06350409's enrollment target sits among peer trials

20,000 5th of 257 higher than 253 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00271180 · 20,000 participants

    Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • NCT00830557 · 20,000 participants

    Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

  • NCT00900471 · 20,000 participants

    Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

  • NCT02735707 · 20,000 participants · Phase 3

    Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06350409, the US trial registry maintained by the National Library of Medicine. NCT06350409 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.